Opin vísindi

International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease

Skoða venjulega færslu

dc.contributor.author The Global Pneumococcal Sequencing Consortium
dc.date.accessioned 2022-04-26T01:03:50Z
dc.date.available 2022-04-26T01:03:50Z
dc.date.issued 2022-02-11
dc.identifier.citation The Global Pneumococcal Sequencing Consortium 2022 , ' International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease ' , Vaccine , vol. 40 , no. 7 , pp. 1054-1060 . https://doi.org/10.1016/j.vaccine.2021.10.046
dc.identifier.issn 0264-410X
dc.identifier.other 45108717
dc.identifier.other 8e7157d3-28bd-4c7f-8895-bea099978275
dc.identifier.other 85122325554
dc.identifier.other 34996643
dc.identifier.other 000750903800013
dc.identifier.uri https://hdl.handle.net/20.500.11815/3080
dc.description Copyright © 2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. Funding Information: We would like to acknowledge the Global Pneumococcal Sequencing project (GPS) and other pneumococcal sequencing projects performed at the Wellcome Sanger Institute whose genomes were screened to identify isolates that could provide context for this analysis, and the Wellcome Sanger Institute Pathogen Informatics Team. The GPS data was supported by the Wellcome Trust, grant number 206194/Z/17/Z, and by the Bill and Melinda Gates Foundation, Investment ID INV-003570. Furthermore, we acknowledge Lene Kolstad, Martha Bjørnstad and Nadia Debech of the Norwegian Institute of Public Health for the analysis of the Norwegian isolates, Brita A Winje for the Norwegian IPD surveillance data and the rest of the outbreak team for their work during the outbreak. We would like to acknowledge Anni Vainio, Milla Hietikko, Elina Yamazaki and Riitta Pulkkinen for laboratory and sequencing work of the Finnish isolates and the outbreak investigation team for their work to control the outbreak. The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Sequencing of outbreak and contemporary IPD surveillance isolates were funded internally in the respective public health institutes. The Global Pneumococcal Sequencing project was funded by Wellcome Trust, grant number 206194/Z/17/Z, and by the Bill and Melinda Gates Foundation, Investment ID INV-003570. J.C. was funded by the European Research Council grant no. 742158. PT is funded by the Wellcome Trust (Thailand-Laos AAP core award, grant no. 220211). Funding Information: We would like to acknowledge the Global Pneumococcal Sequencing project (GPS) and other pneumococcal sequencing projects performed at the Wellcome Sanger Institute whose genomes were screened to identify isolates that could provide context for this analysis, and the Wellcome Sanger Institute Pathogen Informatics Team. The GPS data was supported by the Wellcome Trust, grant number 206194/Z/17/Z, and by the Bill and Melinda Gates Foundation, Investment ID INV-003570. Furthermore, we acknowledge Lene Kolstad, Martha Bjørnstad and Nadia Debech of the Norwegian Institute of Public Health for the analysis of the Norwegian isolates, Brita A Winje for the Norwegian IPD surveillance data and the rest of the outbreak team for their work during the outbreak. Funding Information: Sequencing of outbreak and contemporary IPD surveillance isolates were funded internally in the respective public health institutes. The Global Pneumococcal Sequencing project was funded by Wellcome Trust, grant number 206194/Z/17/Z, and by the Bill and Melinda Gates Foundation, Investment ID INV-003570. J.C. was funded by the European Research Council grant no. 742158. PT is funded by the Wellcome Trust (Thailand-Laos AAP core award, grant no. 220211). Publisher Copyright: © 2021 The Author(s)
dc.description.abstract Background: Pneumococcal disease outbreaks of vaccine preventable serotype 4 sequence type (ST)801 in shipyards have been reported in several countries. We aimed to use genomics to establish any international links between them. Methods: Sequence data from ST801-related outbreak isolates from Norway (n = 17), Finland (n = 11) and Northern Ireland (n = 2) were combined with invasive pneumococcal disease surveillance from the respective countries, and ST801-related genomes from an international collection (n = 41 of > 40,000), totalling 106 genomes. Raw data were mapped and recombination excluded before phylogenetic dating. Results: Outbreak isolates were relatively diverse, with up to 100 SNPs (single nucleotide polymorphisms) and a common ancestor estimated around the year 2000. However, 19 Norwegian and Finnish isolates were nearly indistinguishable (0–2 SNPs) with the common ancestor dated around 2017. Conclusion: The total diversity of ST801 within the outbreaks could not be explained by recent transmission alone, suggesting that harsh environmental and associated living conditions reported in the shipyards may facilitate invasion of colonising pneumococci. However, near identical strains in the Norwegian and Finnish outbreaks does suggest that transmission between international shipyards also contributed to those outbreaks. This indicates the need for improved preventative measures in this working population including pneumococcal vaccination.
dc.format.extent 7
dc.format.extent 521821
dc.format.extent 1054-1060
dc.language.iso en
dc.relation.ispartofseries Vaccine; 40(7)
dc.rights info:eu-repo/semantics/openAccess
dc.subject Sýklafræði
dc.subject Náttúrufræðingar
dc.subject Disease Outbreaks
dc.subject Finland
dc.subject Genome, Bacterial
dc.subject Humans
dc.subject Northern Ireland
dc.subject Norway
dc.subject Occupational Exposure
dc.subject Phylogeny
dc.subject Pneumococcal Infections/epidemiology
dc.subject Polymorphism, Single Nucleotide
dc.subject Serogroup
dc.subject Serotyping
dc.subject Ships
dc.subject Streptococcus pneumoniae
dc.title International links between Streptococcus pneumoniae vaccine serotype 4 sequence type (ST) 801 in Northern European shipyard outbreaks of invasive pneumococcal disease
dc.type /dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article
dc.description.version Peer reviewed
dc.identifier.doi 10.1016/j.vaccine.2021.10.046
dc.relation.url http://www.scopus.com/inward/record.url?scp=85122325554&partnerID=8YFLogxK
dc.contributor.department Other departments
dc.contributor.department Clinical Laboratory Services, Diagnostics and Blood Bank
dc.contributor.department Faculty of Medicine


Skrár

Þetta verk birtist í eftirfarandi safni/söfnum:

Skoða venjulega færslu